ZICC Stock Overview
Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Ziccum AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr6.38 |
| 52 Week High | kr9.90 |
| 52 Week Low | kr3.34 |
| Beta | 1.16 |
| 1 Month Change | -3.33% |
| 3 Month Change | -15.16% |
| 1 Year Change | 33.47% |
| 3 Year Change | -66.63% |
| 5 Year Change | -37.14% |
| Change since IPO | 8.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZICC | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | 4.6% | -6.7% | -0.7% |
| 1Y | 33.5% | 60.6% | 8.7% |
Return vs Industry: ZICC underperformed the Swedish Pharmaceuticals industry which returned 65.2% over the past year.
Return vs Market: ZICC exceeded the Swedish Market which returned 8.1% over the past year.
Price Volatility
| ZICC volatility | |
|---|---|
| ZICC Average Weekly Movement | 6.5% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 13.0% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: ZICC has not had significant price volatility in the past 3 months.
Volatility Over Time: ZICC's weekly volatility has decreased from 12% to 6% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 9 | Ann Gidner | ziccum.com |
Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid biopharmaceuticals, such as vaccines or protein therapeutics into a particle engineered powder product. The company was incorporated in 2017 and is headquartered in Lund, Sweden.
Ziccum AB (publ) Fundamentals Summary
| ZICC fundamental statistics | |
|---|---|
| Market cap | kr98.08m |
| Earnings (TTM) | -kr21.41m |
| Revenue (TTM) | kr6.32m |
15.5x
P/S Ratio-4.6x
P/E RatioIs ZICC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZICC income statement (TTM) | |
|---|---|
| Revenue | kr6.32m |
| Cost of Revenue | kr13.14m |
| Gross Profit | -kr6.82m |
| Other Expenses | kr14.59m |
| Earnings | -kr21.41m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | -1.39 |
| Gross Margin | -108.02% |
| Net Profit Margin | -338.90% |
| Debt/Equity Ratio | 10.0% |
How did ZICC perform over the long term?
See historical performance and comparison